Nuclear
imaging for cardiac diseases helps in accurately diagnosing the disease
and blood flow blockages. Gamma cameras and positron emission
tomography (PET) scanners are the key imaging devices used for cardiac
procedures. Though nuclear imaging in cardiology faces competition from
other methods, the impact is relatively limited. Demand for diagnostic
medical imaging equipment is mainly driven by the number of diagnostic
procedures. The application of PET's clinical use, its combined use with
other imaging equipment and the current shift to PET/CT imaging and
SPECT/CT imaging are the important factors driving the dramatic rise in
procedural volumes. This TriMark Publications study discusses key
products in nuclear cardiology and examines the trends that are
stimulating this market. This market research report includes a survey
of all major companies actively engaged in marketing, manufacturing or
developing nuclear cardiological instrumentation, with each company
discussed in depth. The primarily focus on three major segments of the
nuclear cardiology market: 1) devices, 2) PACS (picture archiving and
communications systems) and RIS (radiology information systems) and 3)
radiopharmaceuticals. This examination discusses products, trends, new
developments and compensation issues that are currently affecting or are
likely to affect the nuclear cardiology market soon. Detailed tables
and charts with sales forecasts and market share data are also included.
1. Overview 51.1 Objectives 5
1.2 Scope 6
1.3 Methodology 6
1.4 Executive Summary 6
2. Medical Imaging Market Analysis 102.1 Medical Imaging Industry Market Size 10
2.2 Medical Imaging Infrastructure 11
2.2.1 Total Healthcare Expenditures and Demographics 11
2.2.2 Number of Hospitals 12
2.2.3 Number of Radiologists 13
2.2.4 Radiology Services 14
2.2.5 Medical Imaging Companies 16
2.2.6 Market Drivers 16
2.2.6.1 Product Enhancements 17
2.2.6.2 Contrast Agents Development 17
2.2.6.3 Innovation 17
2.2.7 Market Restraints 18
2.2.8 Market Segments for Medical Imaging 18
2.2.8.1 Discovery 18
2.2.8.2 Clinical Applications 19
2.2.8.3 Clinical Trials 19
2.2.8.4 Outpatient Facilities 19
2.2.8.5 Technology Advances in Diagnostic Imaging Modalities 19
2.2.8.6 Safety and Ergonomics Concerns 19
2.2.8.7 Volumetric Imaging 20
2.2.8.8 Digital Radiography (DR) 20
2.2.8.9 Contrast Media 21
3. Nuclear Medicine and Nuclear Cardiology Market 293.1 Medical Imaging Industry Forecasts 29
3.2 Hardware Companies (Nuclear Medicine Instrumentation) 30
3.3 Software Companies (Image Processing and PACS) 30
3.4 Radiopharmaceuticals and Pharmaceuticals Companies 31
3.5 Ancillary Products Companies 31
3.6 Service and Support Companies 31
3.7 Nuclear Cardiology Market 31
3.8 Hardware (PET, SPECT and Hybrids) 33
3.8.1 Scanner Investment: Not Just a Cardiology Market 33
3.8.1.1 Impact of Alzheimer’s Reimbursement 34
3.8.2 Sales Trends for PET Scanners 34
3.8.3 Market Consolidation in the U.S. 34
3.8.4 Learning Curve Impact for PET 35
3.8.5 Hardware Market Trends 35
3.9 Software (PACS and RIS) 36
3.10 Radiopharmaceuticals 37
3.10.1 Diagnostic Radiopharmaceuticals 37
3.10.2 Therapeutic Radiopharmaceuticals 37
For more information, please visit:
http://www.aarkstore.com/reports/Nuclear-Cardiology-Markets-1329.html
Or email us at press@aarkstore.com or call +919272852585
1. Overview 51.1 Objectives 5
1.2 Scope 6
1.3 Methodology 6
1.4 Executive Summary 6
2. Medical Imaging Market Analysis 102.1 Medical Imaging Industry Market Size 10
2.2 Medical Imaging Infrastructure 11
2.2.1 Total Healthcare Expenditures and Demographics 11
2.2.2 Number of Hospitals 12
2.2.3 Number of Radiologists 13
2.2.4 Radiology Services 14
2.2.5 Medical Imaging Companies 16
2.2.6 Market Drivers 16
2.2.6.1 Product Enhancements 17
2.2.6.2 Contrast Agents Development 17
2.2.6.3 Innovation 17
2.2.7 Market Restraints 18
2.2.8 Market Segments for Medical Imaging 18
2.2.8.1 Discovery 18
2.2.8.2 Clinical Applications 19
2.2.8.3 Clinical Trials 19
2.2.8.4 Outpatient Facilities 19
2.2.8.5 Technology Advances in Diagnostic Imaging Modalities 19
2.2.8.6 Safety and Ergonomics Concerns 19
2.2.8.7 Volumetric Imaging 20
2.2.8.8 Digital Radiography (DR) 20
2.2.8.9 Contrast Media 21
3. Nuclear Medicine and Nuclear Cardiology Market 293.1 Medical Imaging Industry Forecasts 29
3.2 Hardware Companies (Nuclear Medicine Instrumentation) 30
3.3 Software Companies (Image Processing and PACS) 30
3.4 Radiopharmaceuticals and Pharmaceuticals Companies 31
3.5 Ancillary Products Companies 31
3.6 Service and Support Companies 31
3.7 Nuclear Cardiology Market 31
3.8 Hardware (PET, SPECT and Hybrids) 33
3.8.1 Scanner Investment: Not Just a Cardiology Market 33
3.8.1.1 Impact of Alzheimer’s Reimbursement 34
3.8.2 Sales Trends for PET Scanners 34
3.8.3 Market Consolidation in the U.S. 34
3.8.4 Learning Curve Impact for PET 35
3.8.5 Hardware Market Trends 35
3.9 Software (PACS and RIS) 36
3.10 Radiopharmaceuticals 37
3.10.1 Diagnostic Radiopharmaceuticals 37
3.10.2 Therapeutic Radiopharmaceuticals 37
For more information, please visit:
http://www.aarkstore.com/reports/Nuclear-Cardiology-Markets-1329.html
Or email us at press@aarkstore.com or call +919272852585
No comments:
Post a Comment